MAPK3 and hepatocellular carcinoma: Among all HCC samples, we classified 60 HCC samples with high activation of p-Erk1/2Thr202/Tyr204 and p-mTORSer2448, while 60 with low activation of p-Erk1/2Thr202/Tyr204 and p-mTORSer2448.